GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management

Management Changes View source PDF Explain this filing

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹2721.00

prior close

₹2410.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-3.6%-0.9% vs market

Pharmaceuticals peers, median of 147sector-3.8%-0.6% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Midcap 150 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+7.3

10m

+10.0

15m

+10.2

30m

+8.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5-3.6-0.9-3.8-0.6

Next day

-0.6-1.5+0.9-2.6+2.0

-2.1-2.2+0.0-4.0+1.9

+1.0-0.3+1.3-1.7+2.7

+5.5+2.7+2.8+1.1+4.4

+7.4+3.5+3.9+2.1+5.3

+3.3+6.4-3.0+3.4-0.1

15d

+5.2+5.7-0.5-0.3+5.5

+5.0+6.8-1.8-0.4+5.4

+25.2+17.3+7.9+6.8+18.4

+20.3+17.4+3.0+6.6+13.8

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GlaxoSmithKline Pharmaceuticals Limited has informed the stock exchange about a change in its management. The announcement does not specify the nature of the change, the person involved, or the role affected. Further details are awaited from the company's official disclosure.

Likely market impact

The specific impact on shareholders is unclear until the company discloses who has changed roles and the reasons behind the management change. Investors should watch for follow-up filings with details.